DePuy Synthes Announces Agreement With SERF to Add Dual Mobility System to its Hip Portfolio

DePuy Synthes, the orthopedics business of Johnson & Johnson Medical Devices Companies, plans to add a dual-mobility acetabular cup to its hip portfolio as a result of an agreement between DePuy Ireland Unlimited Company and SERF (Société d’Etude, de Recherche et de Fabrication). SERF is a French-based orthopedics company that has a long heritage in dual-mobility technology.
 
Dual-mobility acetabular cups are designed to increase the stability of the hip implant in patients with a higher risk of dislocation. They feature a standard femoral head articulating within a large polyethylene liner which articulates within a metal shell. These two points of articulation are designed to reduce the risk of dislocation which can impact patient satisfaction, and dual-mobility cups may also reduce the incidence of costly revisions.
 
SERF has long been an innovator in dual-mobility technology, having developed the dual-mobility concept in the 1970s. DePuy Synthes’ portfolio includes the CORAIL Hip Stem, which has a 96.3 percent survivorship at 25 years.¹ “The long-term trust that orthopedic surgeons have placed in both companies’ products is a testament to their demonstrated performance, and we look forward to integrating SERF’s dual-mobility technology with CORAIL and several of our other hip stems,” said Aaron Villaruz, global platform leader, Hips, DePuy Synthes.
 
Per the agreement, DePuy Synthes plans to provide the latest SERF dual-mobility acetabular cup under its own brand name to global markets beginning in the latter half of 2018 subject to regulatory approvals in the US and Europe (additional registrations in certain other geographies are planned to follow).

The Johnson & Johnson Medical Devices Companies have been working to make surgery better for more than a century. With breadth and depth in surgical and orthopaedic technologies and interventional solutions, the company aspires to improve and enhance medical care for people worldwide.

DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies, provides one of the most comprehensive orthopaedics portfolios in the world. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, craniomaxillofacial, spinal surgery and sports medicine, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide.

Reference
1. Vidalain JP (2011) 25-Year ARTRO Results: A Special Vintage from the Old World. In: Vidalain JP et al; The CORAIL Hip System: A Practical Approach Based on 25 Years of Experience. Springer, pg. 94-101